Name
rhi
Label
EndoPat: Reactive Hyperemia Index
Type
numeric
Visit number vs EndoPat: Reactive Hyperemia Index
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
Follow-up | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 9 | 301 |
Treatment Arm vs EndoPat: Reactive Hyperemia Index
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
HLSE | 105 | 2.1 | ± 0.6 | 1.9 | 1.2 | 4.2 | 1 | 106 |
HLSE-O | 102 | 1.9 | ± 0.4 | 1.8 | 1.2 | 3.4 | 4 | 106 |
HLSE-P | 106 | 2.0 | ± 0.5 | 1.9 | 1.0 | 3.4 | - | 106 |
Treatment Arm vs EndoPat: Reactive Hyperemia Index
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 9 | 301 |
HLSE | 97 | 2.2 | ± 0.7 | 2.1 | 1.2 | 5.8 | 3 | 100 |
HLSE-O | 97 | 2.0 | ± 0.6 | 1.9 | 1.0 | 3.9 | 4 | 101 |
HLSE-P | 98 | 2.0 | ± 0.5 | 2.0 | 1.1 | 3.3 | 2 | 100 |
Age category vs EndoPat: Reactive Hyperemia Index
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
45-54 years | 53 | 2.0 | ± 0.5 | 1.9 | 1.0 | 3.1 | - | 53 |
55-64 years | 138 | 2.0 | ± 0.5 | 1.8 | 1.1 | 4.2 | 1 | 139 |
65 years or older | 122 | 2.0 | ± 0.6 | 1.9 | 1.2 | 4.0 | 4 | 126 |
Age category vs EndoPat: Reactive Hyperemia Index
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 8 | 300 |
45-54 years | 48 | 2.0 | ± 0.5 | 1.9 | 1.2 | 3.3 | 1 | 49 |
55-64 years | 124 | 2.0 | ± 0.5 | 1.9 | 1.2 | 3.9 | 3 | 127 |
65 years or older | 120 | 2.2 | ± 0.7 | 2.1 | 1.0 | 5.8 | 4 | 124 |
Gender vs EndoPat: Reactive Hyperemia Index
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
Female | 83 | 2.2 | ± 0.6 | 2.1 | 1.1 | 3.7 | 1 | 84 |
Male | 230 | 1.9 | ± 0.5 | 1.8 | 1.0 | 4.2 | 4 | 234 |
Gender vs EndoPat: Reactive Hyperemia Index
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 9 | 301 |
Female | 77 | 2.2 | ± 0.7 | 2.2 | 1.0 | 4.1 | 2 | 79 |
Male | 215 | 2.0 | ± 0.6 | 1.9 | 1.1 | 5.8 | 7 | 222 |
Race vs EndoPat: Reactive Hyperemia Index
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 308 | 2.0 | ± 0.6 | 1.9 | 1.0 | 4.2 | 5 | 313 |
White | 249 | 2.0 | ± 0.5 | 1.9 | 1.1 | 4.2 | 3 | 252 |
Black | 40 | 2.1 | ± 0.6 | 2.1 | 1.0 | 3.4 | 2 | 42 |
Other | 19 | 2.0 | ± 0.6 | 1.8 | 1.3 | 3.7 | - | 19 |
Race vs EndoPat: Reactive Hyperemia Index
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 288 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 8 | 296 |
White | 232 | 2.1 | ± 0.6 | 2.0 | 1.1 | 5.8 | 5 | 237 |
Black | 37 | 2.1 | ± 0.5 | 2.3 | 1.0 | 3.1 | 3 | 40 |
Other | 19 | 2.0 | ± 0.5 | 2.1 | 1.3 | 3.1 | - | 19 |